Medical Educational Resource
The Champion ALS Study
This program is sponsored by Alexion. This program is not sponsored, endorsed, or accredited by MDA.
The CHAMPION ALS Study is a Phase 3 clinical study in Amyotrophic Lateral Sclerosis (ALS). The purpose of the study is to assess the safety and efficacy of ravulizumab-cwvzto slow the progression in adult patients with ALS with plans to recruit 354 people with ALS in multiple study centers worldwide.